MMG vs. EMG for Cortical Breach Detection

August 1, 2025 updated by: Francis Farhadi

Prospective Evaluation of Mechanomyography Versus Triggered Electromyography for Intraoperative Assessment of Cortical Breaches During Instrumented Lumbar Spine Surgery

The purpose of this study is to determine how well mechanomyography (MMG) and electromyography (EMG) prevent cortical bone breaches, or the pinching of a nerve from screw placement, in patients having lower back surgery requiring hardware. Both MMG and EMG are devices approved by the FDA to detect the location of nerves during surgery so they can be avoided. The results from both tests will be compared to one another to determine if one is better at accurately locating nerves than the other.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

65

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kentucky
      • Lexington, Kentucky, United States, 40536
        • University Of Kentucky

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 76 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • scheduled to undergo a one-, two-, or three-level posterolateral spinal fusion surgery using Depuy Synthes Expedium pedicle screw instrumentation.
  • over the age of 18 years old
  • unresponsive to conservative care for a minimum of 6 months
  • psychosocially, mentally, and physically able to fully consent and comply with this protocol

Exclusion Criteria:

  • preexisting medical condition or comorbidity that makes them a poor candidate
  • open wound local to the operative area, or rapid joint disease, bone absorption, or osteoporosis
  • requires medications that may interfere with bone or soft tissue healing
  • active local or systemic infection
  • metal sensitivity/foreign body sensitivity
  • implanted pacemaker
  • morbidly obese, defined as a body mass index (BMI) greater than 45
  • osteoporosis
  • involved in or planning to engage in litigation or receiving Workers Compensation related to neck or back pain.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intraoperative MMG vs EMG for cortical breach detection
Participants in this arm will be assessed with both MMG and EMG during their lower spine fusion surgery.
Triggered electromyography will be used during surgery to detect nerve impingement by pedicle screws used for spinal fusion. Threshold stimulation data from the device will be recorded.
SENTIO MMG ball tip probe will be used during surgery to detect nerve impingement by pedicle screws used for spinal fusion. Threshold stimulation data from the device will be recorded, and the accuracy compared to the data from the triggered electromyography.
Other Names:
  • SENTIO MMG

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Success of Pedicle Screw Trajectories
Time Frame: 1 hour

Patients with successful pedicle screw trajectories determined by the percentage of patients with A/B or C/D/E breaches.

  • Grade A - No cortical breach (0 mm)
  • Grade B - Pedicle cortical breach < 2 mm
  • Grade C - Pedicle cortical breach = 2 to < 4 mm
  • Grade D - Pedicle cortical breach = 4 to < 6 mm
  • Grade E - Pedicle cortical breach = 6 mm
1 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the Short-From (SF-36) Health Survey
Time Frame: 6 weeks and 3 months after surgery
This survey quantifies how a patient feels about their health, and how well they are able to do common activities. This survey has 9 domains that assess the patients functional ability. The domains are scored as percentages from 0%-100% with 0% being severely limited and 100% being no deficits.
6 weeks and 3 months after surgery
Change From Baseline in the Numeric Rating Scale (NRS) Questionnaire for Pain.
Time Frame: 3 months after surgery
This survey is used to assess pain experienced by the subject and the severity of the pain. Types of pain include numbness, pins and needles, dull aching, burning sensation, muscle cramps, and stabbing pain. Pain severity is rated on a scale of 0-10 where 0 is no pain and 10 is the worst pain imaginable. Pain is assessed in the back and legs. Changes reported as percentages using the formula [(Average measure at 3 months - Average measure at baseline)/Average measure at baseline].
3 months after surgery
Change From Baseline in the Oswestry Disability Index Version 2.1A
Time Frame: 3 months after surgery
This survey is used to quantify disability for low back pain. There are five disability categories ranging from minimally disabled to crippled. The appropriate disability category is determined by the sum of the subjects points divided by the total possible points(50) times 100. This yields a % disabled score and this % determines the appropriate category designation. 0% is equated with no disability and 100% is the maximum disability possible. Changes reported as percentages using the formula [(Average measure at 3 months - Average measure at baseline)/Average measure at baseline]
3 months after surgery
Change From Baseline in the PROMIS Global-10
Time Frame: 3 months after surgery
This questionnaire is a 10 item patient reported tool used to quantify the patients general healthcare related quality of life. It assesses both physical and mental health and is scored as a percentage. Scores closer to 100% report a better quality of life than those who score lower. Changes reported as percentages using the formula [(Average measure at 3 months - Average measure at baseline)/Average measure at baseline]
3 months after surgery
Hospital Readmission at 30 Days
Time Frame: 30 days
Percent of patients undergoing hospital readmission 30 days following the procedure.
30 days
Hospital Readmission at 90 Days
Time Frame: 90 days
Percent of patients undergoing hospital readmission 90 days following the procedure.
90 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: H. Francis Farhadi, MD, PhD, University Of Kentucky

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 2, 2022

Primary Completion (Actual)

July 9, 2024

Study Completion (Actual)

November 6, 2024

Study Registration Dates

First Submitted

April 22, 2022

First Submitted That Met QC Criteria

April 22, 2022

First Posted (Actual)

April 28, 2022

Study Record Updates

Last Update Posted (Actual)

August 19, 2025

Last Update Submitted That Met QC Criteria

August 1, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 76122

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Disorder

Clinical Trials on Triggered Electromyography

Subscribe